Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kalytera Therapeutics Inc (KALY.VN)

Kalytera Therapeutics Inc (KALY.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kalytera Therapeutics Inc 41 Thunderbird Drive Novato CA 94949 USA

P: 415-218-3900

Description:

Kalytera Therapeutics Inc develops cannabinoid (CBD) therapeutics for a range of unmet medical needs. CBD is a compound that shows activity against various pharmacological targets. The company develops CBD formulations and prodrugs to target specific disease sites within the body. Its programs include Bone Fracture Healing Program, Osteogenesis Imperfecta Program, Osteoporosis Program, and Osteoporosis in Prader-Willi syndrome.

Key Statistics

Overview:

Market Capitalization, $K 14,000
Shares Outstanding, K 279,994
Annual Sales, $ 0 K
Annual Net Income, $ 0 K
60-Month Beta 3.25
% of Institutional Shareholders 0.04%

Growth:

1-Year Return -75.61%
3-Year Return 400.00%
5-Year Return 0.00%
5-Year Revenue Growth -80.43%

Per-Share Information:

Next Earnings Date 12/05/18
Earnings Per Share ttm -0.21
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 01/11/17

KALY.VN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -191.57%
Return-on-Assets % -62.15%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book 1.43
Book Value/Share N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar